1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CONTINEUM THERAPEUTICS INC. - ORDINARY SHARES - CLASS A
Contineum Therapeutics Inc. - Ordinary Shares - Class A XNAS: CTNM

Contineum Therapeutics Inc. - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

about

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIP...

Read More
11.75 0.05 (0.43%)
41.95% Fall from 52W High
24,798
XNAS Volume

XNAS 20 Oct, 2025 12:11 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
10.5 / 100
Momentum Score
Technically Moderately Bullish
66.0 / 100
Analyst Price Target
29
1Yr Price target upside is 149%
4 analysts

12

S

4

W

3

O

2

T

SWOT Analysis

Contineum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..